Analysis
Himax Technologies Ends 2025 on Steady Footing as Automotive and AI Demand Support Q4 Performance
Himax Technologies, Inc. (NASDAQ: HIMX) reported steady fourth-quarter fiscal 2025 results, with revenue growth, stable margins, and earnings at the…
Krystal Biotech: Flawless Vyjuvek Launch
Executive summary Krystal Biotech has successfully transitioned into a commercial-stage biotechnology powerhouse following the landmark regulatory approval and rapid market…
